The Food and Drug Administration has approved a blood test to detect concussion that produces results in minutes rather than hours — a breakthrough that could help expedite treatment for service members with traumatic brain injuries, according to the U.S. Army and Abbott Laboratories, the…
Read Next: New Cold-Assignment Incentive Pay Coming for Airmen and Guardians at 7 Bases
“This can help get the most severely injured service members to neurosurgeons faster and ultimately save lives,” Lt. Col. Bradley Dengler, neurosurgical consultant to the U.S. Army Office of the Surgeon General, said in a release.
The test was developed by Abbott with the U.S. Army Medical Materiel Development Activity, part of U.S. Army Medical Research and Development Command. It measures the levels of two head injury biomarkers — glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase — in a blood sample, with results produced bedside within 15 minutes.
Comments are closed.